Quidel QuickVue® SARS-CoV-2 COVID-19 Antigen Rapid Test POINT-OF-CARE CLIA WAIVED 195-000, 25 Test Kits/Box
Quidel QuickVue® SARS-CoV-2 COVID-19 Antigen Rapid Test POINT-OF-CARE CLIA WAIVED 195-000, 25 Test Kits/Box
***NOTE: EXPIRATION DATE ON BOX HAS PASSED. NO CANCELLATIONS, RETURNS, REFUNDS, STORE CREDITS OR SHIPMENT REROUTES. ALL SALES ARE FINAL.***
FDA Emergency Use Authorization
The QuickVue SARS Antigen Test detects SARS-CoV-2 antigens directly from anterior nares swab specimens. The QuickVue SARS Antigen Test provides accurate and reliable results in 10 minutes, allowing for COVID-19 testing of symptomatic patients within the first five days of symptoms and asymptomatic patients when tested serially.
Healthcare professionals can purchase the QuickVue SARS Antigen Test through select authorized distributors.
- For Rapid Detection of SARS-CoV-2 | FDA EUA | IVD Use | RX Only
Lateral flow assay - Rapid results in 10 minutes
- Nasopharyngeal swab specimen collection
- Intended at POC setting (i.e., in patient care settings) by medical professionals operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation
- Detect SARS-CoV-2 nucleocapsid protein antigen
- Identify acute infection in symptomatic patients with 88.4% sensitivity and 100% specificity
- Designated as a CLIA waived tests
Where can I go for updates and more information?
CDC:
General Information - Coronavirus (COVID-19)
Information for Healthcare Professionals
Information for Laboratories
Laboratory Biosafety
Isolation Precautions in Healthcare Settings
Specimen Collection
Infection Control
FDA:
General Information - Coronavirus (COVID-19)
Emergency Use Authorizations
Additional Information - Quidel's EUA COVID-19 Products (Scroll down to the list of EUA products and enter “Quidel” in the search box)
QuickVue SARS Antigen Test - Instructions for Use
QuickVue SARS Antigen Test - Patient Fact Sheet
-
- Create an account for special pricing when buying large quantities
- Only 1 item in stock
